Novo Nordisk A/S (NVO)

NYSE: NVO · IEX Real-Time Price · USD
128.40
+0.35 (0.27%)
At close: Mar 28, 2024, 4:00 PM
128.60
+0.20 (0.16%)
After-hours: Mar 28, 2024, 7:59 PM EDT

Total Valuation

Novo Nordisk has a market cap or net worth of $574.20 billion. The enterprise value is $573.73 billion.

Market Cap 574.20B
Enterprise Value 573.73B

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, before market open.

Earnings Date May 2, 2024
Ex-Dividend Date Mar 22, 2024

Share Statistics

Novo Nordisk has 4.46 billion shares outstanding.

Shares Outstanding 4.46B
Owned by Insiders (%) 0.00%
Owned by Institutions (%) 9.29%
Float 3.19B

Valuation Ratios

The trailing PE ratio is 47.66 and the forward PE ratio is 38.17. Novo Nordisk's PEG ratio is 2.35.

PE Ratio 47.66
Forward PE 38.17
PS Ratio 16.69
Forward PS 2.00
PB Ratio 37.30
P/FCF Ratio 47.83
PEG Ratio 2.35
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.69, with an EV/FCF ratio of 47.79.

EV / Earnings 46.28
EV / Sales 16.67
EV / EBITDA 34.69
EV / EBIT 37.80
EV / FCF 47.79

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.25.

Current Ratio 0.82
Quick Ratio 0.56
Debt / Equity 0.25
Debt / EBITDA 0.24
Debt / FCF 0.32
Interest Coverage 277.92

Financial Efficiency

Return on equity (ROE) is 90.50% and return on invested capital (ROIC) is 61.40%.

Return on Equity (ROE) 90.50%
Return on Assets (ROA) 29.20%
Return on Capital (ROIC) 61.40%
Revenue Per Employee $534,975
Profits Per Employee $192,750
Employee Count 64,319
Asset Turnover 0.81
Inventory Turnover 1.27

Taxes

In the past 12 months, Novo Nordisk has paid $3.03 billion in taxes.

Income Tax 3.03B
Effective Tax Rate 19.65%

Stock Price Statistics

The stock price has increased by +65.34% in the last 52 weeks. The beta is 0.18, so Novo Nordisk's price volatility has been lower than the market average.

Beta (1Y) 0.18
52-Week Price Change +65.34%
50-Day Moving Average 121.86
200-Day Moving Average 100.38
Relative Strength Index (RSI) 52.42
Average Volume (30 Days) 5,207,737

Short Selling Information

Short Interest 4.11M
Short Previous Month 4.67M
Short % of Shares Out 0.14%
Short % of Float n/a
Short Ratio (days to cover) 0.88

Income Statement

In the last 12 months, Novo Nordisk had revenue of $34.41 billion and earned $12.40 billion in profits. Earnings per share was $2.69.

Revenue 34.41B
Gross Profit 28.39B
Operating Income 14.82B
Pretax Income 15.12B
Net Income 12.40B
EBITDA 16.54B
EBIT 15.18B
Earnings Per Share (EPS) $2.69
Full Income Statement

Balance Sheet

The company has $4.37 billion in cash and $3.90 billion in debt, giving a net cash position of $465.79 million or $0.10 per share.

Cash & Cash Equivalents 4.37B
Total Debt 3.90B
Net Cash 465.79M
Net Cash Per Share $0.10
Equity / Book Value 15.40B
Book Value Per Share 3.45
Working Capital -4.34B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $15.73 billion and capital expenditures -$3.73 billion, giving a free cash flow of $12.01 billion.

Operating Cash Flow 15.73B
Capital Expenditures -3.73B
Free Cash Flow 12.01B
FCF Per Share $2.63
Full Cash Flow Statement

Margins

Gross margin is 82.50%, with operating and profit margins of 43.07% and 36.03%.

Gross Margin 82.50%
Operating Margin 43.07%
Pretax Margin 43.95%
Profit Margin 36.03%
EBITDA Margin 48.06%
EBIT Margin 44.11%
FCF Margin 34.89%

Dividends & Yields

This stock pays an annual dividend of $0.70, which amounts to a dividend yield of 0.55%.

Dividend Per Share $0.70
Dividend Yield 0.55%
Dividend Growth (YoY) 796.94%
Years of Dividend Growth 4
Payout Ratio 26.02%
Buyback Yield -0.81%
Shareholder Yield -0.27%
Earnings Yield 2.16%
FCF Yield 2.09%
Dividend Details

Analyst Forecast

The average price target for Novo Nordisk is $104.10, which is -18.93% lower than the current price. The consensus rating is "Strong Buy".

Price Target $104.10
Price Target Difference -18.93%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 13.54%
EPS Growth Forecast (5Y) 14.23%
Stock Forecasts

Stock Splits

The last stock split was on September 20, 2023. It was a forward split with a ratio of 2:1.

Last Split Date Sep 20, 2023
Split Type Forward
Split Ratio 2:1

Scores

Novo Nordisk has an Altman Z-Score of 13.68 and a Piotroski F-Score of 7.

Altman Z-Score 13.68
Piotroski F-Score 7